The Latest Cardiac and Vascular News
VANCOUVER, British Columbia–(BUSINESS WIRE)–Aegis Medical Innovations Inc. (Aegis) today announced that it has received Investigational Device Exemption approval from the U.S. FDA to initiate a clinical trial in the U.S. for its medical device called the Sierra Ligation System (Sierra). Aegis developed the Sierra technology in partnership with the Mayo […]
DIAMOND BAR, California, March 22, 2017 /PRNewswire/ — Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today the launch of the CARTO VISITAG™ Module with Ablation Index, a new technology providing visual indication based on the […]
MILFORD, MA — (Marketwired) — 03/22/17 — A new meta-analysis presented this week at the American College of Cardiology further supports the ability of RenalGuard Therapy® to significantly reduce the incidence of acute kidney injury associated with cardiovascular interventional procedures compared to other methods of urine volume expansion. Moreover, findings […]
FITCHBURG, Mass., March 22, 2017 (GLOBE NEWSWIRE) — Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the “Company”), through its wholly-owned subsidiary, Micron Products, Inc., a diversified contract manufacturing organization that produces highly-engineered, innovative medical device components requiring precision machining and injection molding, announced results for its fourth quarter and year ended […]
WAYNE, Pa.–(BUSINESS WIRE)– Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial has completed enrollment. A total of 210 patients have been enrolled in TOBA II at 33 sites in the U.S. […]
AUSTIN, Texas, March 21, 2017 /PRNewswire/ — On March 1, 2017, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center was the first in Texas and among the first facilities in the U.S. to use the FlexAbility™ Ablation Catheter, Sensor Enabled™, designed to improve versatility and precision during […]
DURHAM, N.C.–(BUSINESS WIRE)– Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced that the first U.S. commercial case using the Tryton Side Branch Stent to treat a coronary bifurcation lesion involving a large side branch (appropriate for a ≥2.5mm stent) was completed at […]
QT Vascular Secures Up To S$20 Million Capital Commitment GEM Global SINGAPORE, March 21, 2017 /PRNewswire/ — QT Vascular Ltd., (the “Company” or “QT Vascular“, and together with its subsidiaries, the “Group“) announced that it has signed an agreement (“Agreement“) with GEM Global Yield Fund LLC SCS (“GEM Global“), the New York based […]
BioStable Science & Engineering Announces FDA Clearance of the HAART™ 300 Aortic Annuloplasty Device AUSTIN, Texas–(BUSINESS WIRE)–BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal annuloplasty device designed for aortic valve repair. BioStable expects […]
Press Release Medtronic Receives FDA Approval for CoreValve(TM) Evolut(TM) Pro Transcatheter Valve with Advanced Sealing DUBLIN – March 22, 2017 – Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM)Evolut(TM) PRO valve for the treatment of severe aortic stenosis for symptomatic […]
